G6PD was discovered and biochemically characterized in 1932 by Otto Warburg and Walter
Christian 1 in yeast and in red cells as an enzyme with a redox function. It was one of the first …

Purpose The pathophysiology, diagnosis, and medication-use implications of glucose-6-
phosphate dehydrogenase (G6PD) deficiency, the most common enzyme deficiency in …

G6PD was discovered and biochemically characterized in 1932 by Otto Warburg and Walter
Christian 1 in yeast and in red cells as an enzyme with a redox function. It was one of the first …

Oxidative agents can cause acute haemolytic anaemia in persons with G6PD deficiency.
Understanding the relationship between G6PD genotype and the phenotypic expression of …

Background Helminths are among the most widespread infectious agents prevalent in
tropical and sub-tropical regions of the developing world defined by inadequate sanitation …

Background To reduce the risk of drug-induced haemolysis, all patients should be tested for
glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PDd) prior to prescribing …

Background Patients infected by Plasmodium vivax or Plasmodium ovale suffer repeated
clinical attacks without primaquine therapy against latent stages in liver. Primaquine causes …

Background G6PD enzyme deficiency is a common enzymatic X-linked disorder. Deficiency
of the G6PD enzyme can cause free radical-mediated oxidative damage to red blood cells …

Background Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme essential for
NADPH production and protecting cells, especially red blood cells, from free radicals. The …

Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-
linked genetic disorder that results in impaired enzyme activity. Although G6PD deficiency is …